BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29869464)

  • 1. Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
    Ki EY; Lee YK; Lee A; Park JS
    Yonsei Med J; 2018 Jul; 59(5):662-668. PubMed ID: 29869464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2.
    Lee DH; Hwang NR; Lim MC; Yoo CW; Joo J; Kim JY; Park SY; Hwang SH
    Ann Clin Biochem; 2016 Sep; 53(Pt 5):561-7. PubMed ID: 26486441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
    Yu S; Kwon MJ; Lee EH; Park H; Woo HY
    J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
    Park Y; Lee E; Choi J; Jeong S; Kim HS
    J Clin Microbiol; 2012 Jul; 50(7):2359-65. PubMed ID: 22518863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+ in two time periods.
    Bottari F; Boveri S; Iacobone AD; Gulmini C; Igidbashian S; Cassatella MC; Landoni F; Sandri MT
    Infect Dis (Lond); 2018 Jul; 50(7):554-559. PubMed ID: 29463149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
    Castle PE; Eaton B; Reid J; Getman D; Dockter J
    J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.
    Gillio-Tos A; De Marco L; Carozzi FM; Del Mistro A; Girlando S; Burroni E; Frayle-Salamanca H; Giorgi Rossi P; Pierotti P; Ronco G;
    J Clin Microbiol; 2013 Sep; 51(9):2901-7. PubMed ID: 23804385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and genotyping of human papillomavirus by five assays according to cytologic results.
    Choi J; Park Y; Lee EH; Kim S; Kim JH; Kim HS
    J Virol Methods; 2013 Jan; 187(1):79-84. PubMed ID: 22982075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
    Kwon MJ; Roh KH; Park H; Woo HY
    J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical performance of human papillomavirus genotyping using PANArray HPV chip: Comparison to ThinPrep cytology alone and co-testing.
    Kim J; Jun SY; Maeng LS
    Pathol Res Pract; 2020 Sep; 216(9):153121. PubMed ID: 32825927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
    Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
    Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytic performance of PANArray HPV and HPV 9G DNA chip tests for genotyping of high-risk human papillomavirus in cervical ThinPrep PreservCyt samples.
    Kim J; Jun SY
    PLoS One; 2019; 14(10):e0224483. PubMed ID: 31671125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
    Oštrbenk A; Xu L; Arbyn M; Poljak M
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30209184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
    Lindemann ML; Dominguez MJ; de Antonio JC; Sandri MT; Tricca A; Sideri M; Khiri H; Ravet S; Boyle S; Aldrich C; Halfon P
    J Mol Diagn; 2012 Jan; 14(1):65-70. PubMed ID: 22079749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening].
    Mateos ML; Chacón de Antonio J; Rodríguez-Domínguez M; Sanz I; Rubio MD
    Enferm Infecc Microbiol Clin; 2011; 29(6):411-4. PubMed ID: 21435749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.